GlassScriptPhysician profile
Andrew Blythe
NPI 1336786383
$780.82
in general payments reported to CMS, 2019-2025
10 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.33 · 2022: $306 · 2023: $85.14 · 2024: $104 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $321.45 | 2024-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Grt US Holding, INC. | $254.98 | 2021-2022 | |
| Spr Therapeutics, INC | $57.77 | 2023 | Sprint Pns System |
| Nalu Medical, INC. | $42.97 | 2024 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $27.37 | 2023 | Qutenza |
| Fidia Pharma USA INC. | $22.20 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.62 | 2022 | |
| Medtronic, INC. | $14.49 | 2022 | |
| Convatec INC. | $13.37 | 2022 | |
| Collegium Pharmaceutical, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Blythe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.